Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Stereotactic Body Radiotherapy (SBRT) for High-Risk Localized Prostrate Cancer

NCT02296229 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02296229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Stereotactic Body Radiotherapy (SBRT) for High-Risk Localized Prostrate Cancer
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 27, 2014
Completion date
January 27, 2027
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate, stage iii prostate cancer